The soybean cultivar BR 36 with conventional levels of trypsin inhibitors a
ctivity and the soybean line BRM95-5262, which was genetically selected to
contain low activity of trypsin inhibitors were used for biological assays
with rats. BR 36 and BRM95-5262 contained 40 and 20, and 30 and 20% of rela
tive residual activity of trypsin inhibitors, respectively. The mean values
of PER and NPR showed that treatments with crude soybeans were minor than
treatments with soybean thermically processed. However, the treatments of t
hermically processed soybean did not showed significative differences (p gr
eater than or equal to0.05). When the trypsin inhibitors activity were 8.61
and 8.44 UIT/mg of samples or 20 and 30% of relative residual activity of
cultivar BR 36 and line BRM95-5262, respectively, it was observed that mean
values of PER and NPR were not significatives. The mean values of CDA and
CDV of treatments with crude soybeans were minor than treatment with casein
and similar to the treatments with soybean thermically processed. So, it c
an be concluded that the biological evaluation obtained with soybean protei
n were dependent of initial trypsin inhibitors activities and of its respec
tive thermical treatment. There was advantage in the use of BRM95-5262 soyb
ean line with low trypsin inhibitors activity.